Lupin Diagnostics eyes 100 labs in five years

Lupin Diagnostics Ltd., a wholly owned subsidiary of Lupin Ltd., has drawn up plans to more than double the number of its laboratories and increase collection centres by threefold across the country in five years, said a top official.

“Right now, we have 36 laboratories and 600 collection centres. Our goal is to have 100 laboratories by FY28 and 2,000 collection centres in five years,” said CEO Ravindra Kumar during a press meet.

On Thursday, Mr. Kumar announced the launch of Regional Reference laboratory in Chennai. Plans are to enter tier II cities such as Coimbatore, Madurai, Tiruchiraplli and Salem and agreements have been signed with the franchisees, he said.

Regarding the expansion of laboratories, he said that each region will have at least 25 units. “Right now, we are present only in East, West and South. We will be entering North by FY27, Kerala and Gujarat soon.”

The number of collection centres will be ramped to 1,000 numbers by FY25 and 2,000 in three years.

While mentioning that 10 out of 36 laboratories have already been accredited by NABL, he said that 10 more are in the pipeline and five would get the accreditation by FY24.

Related Posts

  • Pharma
  • December 23, 2024
  • 66 views
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

  • Pharma
  • December 23, 2024
  • 94 views
NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt